Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGCHIX:MEDXZ -0.22%70 Return-on-Tangible-Asset is 0.17% as of Jun. 2026, which is 92% below its 10-year median of 2.24. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 70/100 and a GF Value™ of CHF9.06 (Fairly Valued). The stock has 6 warning signs investors should review. Among 3,076 Industrial Products companies, Medmix AG ranks worse than 73.15% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Medmix AG's annualizedNet Income for the quarter that ended in Jun. 2026 was CHF1.0 Mil. Medmix AG's average total tangible assets for the quarter that ended in Jun. 2026 was CHF596.6 Mil. Therefore, Medmix AG's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 0.17%.
The historical rank and industry rank for Medmix AG's Return-on-Tangible-Asset or its related term are showing as below:
CHIX:MEDXz'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -1.26 Med: 2.24 Max: 15.49
Current: 0.02
During the past 8 years, Medmix AG's highest Return-on-Tangible-Asset was 15.49%. The lowest was -1.26%. And the median was 2.24%.
CHIX:MEDXz's Return-on-Tangible-Asset is ranked worse than 73.15% of 3076
companies
in the Industrial Products industry
Industry Median: 3.335
vs CHIX:MEDXz: 0.02
Medmix AG (CHIX:MEDXz) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Medmix AG Return-on-Tangible-Asset Related Terms
Medmix AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Medmix AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:MEDXZ vs GEV, ETN, PH: Return-on-Tangible-Asset Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Return-on-Tangible-Asset vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Medmix AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 0.17% mean?
Medmix AG (CHIX:MEDXZ) has a Return-on-Tangible-Asset of 0.17% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medmix AG and its competitors. This is 92% below median its historical median of 2.24. According to the industry distribution chart, Medmix AG ranks #2250 out of 3076 companies in the Industrial Products industry, placing it in the top 73.1%.
Is Medmix AG's Return-on-Tangible-Asset too high?
Medmix AG's current Return-on-Tangible-Asset of 0.17% is 92% below median its 10-year median of 2.24. The Industrial Products industry median Return-on-Tangible-Asset is 3.34. Medmix AG's value of 0.17% is 94.9% below this industry median. Based on the distribution chart, Medmix AG ranks #2250 out of 3076 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Medmix AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Return-on-Tangible-Asset compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #2250 out of 3076 companies for Return-on-Tangible-Asset. This places Medmix AG in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.34. Medmix AG's value of 0.17% is 94.9% below this benchmark. While the company's 10-year median is 2.24 vs. the industry median of 3.34, Medmix AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for an Industrial Products company?
The median Return-on-Tangible-Asset among Industrial Products companies is 3.34, based on 3,076 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current Return-on-Tangible-Asset of 0.17% is 94.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median Return-on-Tangible-Asset is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current Return-on-Tangible-Asset is 0.17%, which is 92% below median its own 10-year median of 2.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.06, compared to a current price of CHF9.15 — trading 1% above its estimated fair value. The current Return-on-Tangible-Asset is 0.17%, which is 92% below median its 10-year median of 2.24 and 94.9% below the Industrial Products industry median of 3.34. Medmix AG's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Return-on-Tangible-Asset is 0.17% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be overvalued.
The current stock price of CHF9.15 is trading 1% above its estimated GF Value™ of CHF9.06.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
Return-on-Tangible-Asset: 0.17% (92% below median its 10-year median of 2.24)
GF Value™: CHF9.06 vs. price of CHF9.15 (1% above fair value)
Industry Position: 94.9% below the Industrial Products median (#2250 of 3076)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
70GF Score
Get the complete analysis for CHIX:MEDXZ
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
